Cas no 475060-42-5 (N-Methylpiperidine-3-carboxamide hydrochloride)
N-Methylpiperidine-3-carboxamide hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- N-Methylpiperidine-3-carboxamide hydrochloride
- N-Methyl-3-piperidinecarboxamide hydrochloride
- PIPERIDINE-3-CARBOXYLIC ACID METHYLAMIDEHYDROCHLORIDE
- Piperidine-3-carboxylic acid methylamide hydrochloride
- N-methylpiperidine-3-carboxamide;hydrochloride
- DB-266646
- N-Methylpiperidine-3-carboxamide--hydrogen chloride (1/1)
- Z1266933838
- AKOS015845993
- F2145-0666
- PIPERIDINE-3-CARBOXYLIC ACID METHYL AMIDE, HYDROCHLORIDE
- SCHEMBL5908246
- N-Methyl-3-piperidinecarboxamide HCl
- 475060-42-5
- GJIWAHKHYCEKFG-UHFFFAOYSA-N
- MFCD09064923
- CS-0094687
- D75606
- SY343751
- SB37287
- CS-16284
- N-methylpiperidine-3-carboxamidehydrochloride
- EN300-74129
- DTXSID80622209
- N3-methyl-3-piperidinecarboxamide hydrochloride
- N-Methyl-3-piperidinecarboxamide hydrochloride, AldrichCPR
-
- MDL: MFCD09064923
- Inchi: 1S/C7H14N2O.ClH/c1-8-7(10)6-3-2-4-9-5-6;/h6,9H,2-5H2,1H3,(H,8,10);1H
- InChI Key: GJIWAHKHYCEKFG-UHFFFAOYSA-N
- SMILES: Cl.O=C(C1CNCCC1)NC
Computed Properties
- Exact Mass: 178.08700
- Monoisotopic Mass: 178.0872908g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 2
- Complexity: 125
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 41.1?2
Experimental Properties
- PSA: 41.13000
- LogP: 1.25370
N-Methylpiperidine-3-carboxamide hydrochloride Security Information
- Hazard Category Code: 22
-
Hazardous Material Identification:
- HazardClass:IRRITANT
N-Methylpiperidine-3-carboxamide hydrochloride Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
N-Methylpiperidine-3-carboxamide hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 029249-250mg |
Piperidine-3-carboxylic acid methylamide hydrochloride |
475060-42-5 | 95% | 250mg |
£124.00 | 2022-03-01 | |
| Fluorochem | 029249-1g |
Piperidine-3-carboxylic acid methylamide hydrochloride |
475060-42-5 | 95% | 1g |
£232.00 | 2022-03-01 | |
| Fluorochem | 029249-5g |
Piperidine-3-carboxylic acid methylamide hydrochloride |
475060-42-5 | 95% | 5g |
£744.00 | 2022-03-01 | |
| Fluorochem | 029249-10g |
Piperidine-3-carboxylic acid methylamide hydrochloride |
475060-42-5 | 95% | 10g |
£1225.00 | 2022-03-01 | |
| Alichem | A129004347-1g |
N-Methylpiperidine-3-carboxamide hydrochloride |
475060-42-5 | 95% | 1g |
$211.12 | 2023-09-01 | |
| Alichem | A129004347-5g |
N-Methylpiperidine-3-carboxamide hydrochloride |
475060-42-5 | 95% | 5g |
$636.48 | 2023-09-01 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 60R0452S-1g |
Piperidine-3-carboxylic acid methylamide hydrochloride |
475060-42-5 | 97% | 1g |
5071.29CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 60R0452S-5g |
Piperidine-3-carboxylic acid methylamide hydrochloride |
475060-42-5 | 97% | 5g |
16943.89CNY | 2021-05-08 | |
| Matrix Scientific | 052715-500mg |
N-Methyl-3-piperidinecarboxamide hydrochloride |
475060-42-5 | 500mg |
$237.00 | 2023-09-10 | ||
| Matrix Scientific | 052715-2.5g |
N-Methyl-3-piperidinecarboxamide hydrochloride |
475060-42-5 | 2.5g |
$720.00 | 2023-09-10 |
N-Methylpiperidine-3-carboxamide hydrochloride Related Literature
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
-
Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
-
Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
Additional information on N-Methylpiperidine-3-carboxamide hydrochloride
Comprehensive Overview of N-Methylpiperidine-3-carboxamide hydrochloride (CAS No. 475060-42-5)
N-Methylpiperidine-3-carboxamide hydrochloride (CAS No. 475060-42-5) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research. This compound, often referred to as N-Methyl-3-piperidinecarboxamide HCl, is a hydrochloride salt form of a piperidine derivative. Its unique structural features make it a valuable intermediate in the synthesis of various bioactive molecules, particularly in the development of central nervous system (CNS) targeting drugs.
The chemical structure of N-Methylpiperidine-3-carboxamide hydrochloride consists of a piperidine ring substituted with a methyl group at the nitrogen atom and a carboxamide group at the 3-position. The hydrochloride salt form enhances its solubility in aqueous solutions, making it more suitable for various pharmaceutical applications. Researchers have shown increasing interest in this compound due to its potential role in modulating neurotransmitter systems, which is a hot topic in current neuropharmacology and drug discovery.
In recent years, the demand for piperidine derivatives like N-Methylpiperidine-3-carboxamide HCl has surged, driven by the growing focus on CNS drug development. This trend aligns with the increasing prevalence of neurological disorders and the need for more effective treatments. The compound's versatility as a building block in organic synthesis has made it particularly valuable in medicinal chemistry, where researchers are constantly seeking novel scaffolds for drug design.
From a physicochemical perspective, N-Methylpiperidine-3-carboxamide hydrochloride typically appears as a white to off-white crystalline powder. It exhibits good stability under standard storage conditions, though it should be protected from excessive moisture and light. The compound's molecular weight is approximately 178.67 g/mol, and it demonstrates moderate solubility in water and various organic solvents, properties that are crucial for its pharmaceutical formulation applications.
The synthesis of N-Methylpiperidine-3-carboxamide hydrochloride typically involves multi-step organic reactions starting from commercially available piperidine derivatives. Modern synthetic approaches often employ green chemistry principles to improve yield and reduce environmental impact, reflecting the current industry focus on sustainable chemical production. These methods may include catalytic processes or solvent-free reactions that align with the growing demand for eco-friendly synthesis in the pharmaceutical industry.
In pharmacological research, N-Methylpiperidine-3-carboxamide hydrochloride has shown promise as a precursor for compounds targeting various receptor systems. Its structural features make it particularly interesting for the development of neuromodulators and psychoactive compounds, though all such applications require thorough clinical evaluation. The current scientific literature suggests potential utility in areas such as cognitive enhancement and mood regulation, which are among the most searched topics in neuroscience research today.
The global market for pharmaceutical intermediates like N-Methylpiperidine-3-carboxamide HCl has been expanding steadily, driven by increased R&D investment in drug discovery. Market analysts note particular growth in the segment of CNS-active compounds, with this piperidine derivative positioned as a valuable scaffold for new drug candidates. The compound's commercial availability from specialized chemical suppliers has made it accessible to researchers worldwide, facilitating its investigation across various therapeutic areas.
Quality control of N-Methylpiperidine-3-carboxamide hydrochloride is maintained through rigorous analytical techniques including HPLC, NMR spectroscopy, and mass spectrometry. These methods ensure the compound meets the high purity standards required for pharmaceutical research, typically ≥98% purity for most applications. The analytical characterization also helps researchers understand the compound's stability profile and potential degradation pathways, information that's crucial for its formulation development.
From a regulatory standpoint, N-Methylpiperidine-3-carboxamide hydrochloride is generally classified as a research chemical when used in laboratory settings. Its handling requires standard laboratory precautions, and researchers must consult relevant chemical safety guidelines when working with this material. The compound's status may vary by jurisdiction, so users should always verify local regulations before procurement or use.
The future research directions for N-Methylpiperidine-3-carboxamide HCl appear promising, with several published studies exploring its incorporation into more complex molecular architectures. Current scientific trends suggest potential applications in developing targeted therapies for neurological conditions, an area receiving substantial research funding globally. The compound's versatility as a synthetic intermediate positions it well for continued investigation in medicinal chemistry programs worldwide.
In conclusion, N-Methylpiperidine-3-carboxamide hydrochloride (CAS No. 475060-42-5) represents an important building block in modern pharmaceutical research. Its unique structural features and potential biological activities make it a compound of significant interest to both academic and industrial researchers. As the field of neuropharmaceuticals continues to evolve, this piperidine derivative is likely to maintain its relevance in drug discovery efforts targeting the central nervous system and beyond.
475060-42-5 (N-Methylpiperidine-3-carboxamide hydrochloride) Related Products
- 1220034-18-3(N-propylpiperidine-3-carboxamide hydrochloride)
- 189763-34-6(6-oxopiperidine-3-carboxamide)
- 937725-10-5(N-butylpiperidine-3-carboxamide hydrochloride)
- 883554-87-8(N-(2-methylpropyl)piperidine-3-carboxamide)
- 1124199-15-0((3R)-N-methylpiperidine-3-carboxamide)
- 5115-98-0(N-Methylpiperidine-3-carboxamide)
- 937725-06-9(N-isopropylpiperidine-3-carboxamide hydrochloride)
- 937725-08-1(N-(2-methylpropyl)piperidine-3-carboxamide hydrochloride)
- 112989-90-9(N-ethylpiperidine-3-carboxamide hydrochloride)
- 1181265-43-9(2,8-diazaspiro[5.5]undecan-1-one;hydrochloride)